Welcome to our dedicated page for Gallagher (ARTHUR J.) & Co. SEC filings (Ticker: AJG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Arthur J. Gallagher & Co. filings document the reporting record of a global insurance brokerage, risk management and consulting services company with common stock listed on the New York Stock Exchange under AJG. Its 8-K filings regularly report operating results and financial condition, including earnings releases, GAAP and non-GAAP measures, supplemental quarterly data and CFO commentary furnished through Regulation FD disclosures.
The company’s SEC filings also cover proxy governance, executive compensation, director elections, board composition and shareholder meeting matters. Material-event reports document investor presentations, board changes, securities registration information and completed acquisition accounting, including acquired-company financial statements and pro forma financial information for the AssuredPartners transaction.
Arthur J. Gallagher & Co. is providing an informational update about an investor meeting held on June 17, 2026. This communication is made under Regulation FD, which is intended to ensure fair disclosure to all investors.
The company notes that a webcast of the meeting and related presentation materials, including an updated “CFO Commentary”, are available on its investor relations website. The CFO Commentary contains certain estimates for 2026 results and includes cautionary language about forward-looking statements.
Pershing LLC submitted a Form 144 reporting a proposed sale of 15,000 shares of Common Stock of AJG listed on the Nasdaq. The filing records an open-market purchase entry dated 01/01/2012 and enumerates multiple recent open-market sales executed by Matrix Trust Company between 03/18/2026 and 06/11/2026, each showing trade date, share count, and dollar amounts.
Arthur J. Gallagher & Co. controller and chief accounting officer Richard C. Cary reported an open-market sale of 3,000 shares of common stock at $206.00 per share on June 2, 2026. After this transaction, he directly holds 47,819.487 shares of common stock, along with 418.699 shares held indirectly through a Gallagher 401(k) plan account.
He also holds equity-based awards, including phantom stock and notional stock units, each representing rights to receive Gallagher common stock, and several non-qualified stock options covering 1,219, 1,572, 2,265, and 2,349 underlying shares with exercise prices between $86.17 and $177.09 per share and expirations from 2027 to 2030.
Arthur J. Gallagher & Co. director David S. Johnson reported acquiring 236.536 shares of common stock valued at $206.10 per share. This reflects his prior election under the Company’s Director Deferral Plan to defer his annual cash retainer into deferred share units payable in stock. Following this compensation-related grant, he holds 47,386.554 shares of common stock directly.
Arthur J. Gallagher & Co. director Christopher C. Miskel acquired 194.081 shares of common stock on June 1, 2026 at a reference price of $206.10 per share. This was a grant under the company’s Director Deferral Plan, converting deferred cash retainers into share units, bringing his direct holdings to 10,641.773 shares.
Arthur J. Gallagher & Co. Chief Operating Officer Patrick Murphy Gallagher reported a Form 4 showing a bona fide gift of 14,698 shares of common stock made indirectly through a trust. The trust still holds 98,105.25 shares of Gallagher common stock following this gift.
The filing also updates various indirect family trusts and a 401(k) account, as well as direct holdings of common stock, notional stock units, phantom stock and several non-qualified stock options with exercise prices ranging from $86.17 to $337.74 and expirations between 2027 and 2033.
Arthur J. Gallagher & Co. CEO J. Patrick Gallagher Jr. reported a Form 4 showing a bona fide gift of 14,698 shares of common stock, transferred at a reported price of $0.00 per share. Following the gift, he directly holds 109,416.9637 common shares, along with additional indirect holdings through various trusts, a 401(k) plan account, and his spouse. He also retains multiple non-qualified stock options with different exercise prices and expiration dates, plus phantom stock and notional stock units that each represent rights to receive one share of Gallagher common stock.
Caplan Deborah H reported acquisition or exercise transactions in this Form 4 filing.
Director Deborah H. Caplan received a grant of 1,110 shares of Arthur J. Gallagher & Co. common stock in the form of a restricted stock unit award. The units vest on the earlier of one year after the grant date or her departure from the Board. Following this award, she directly holds 2,650 shares of common stock.
Arthur J. Gallagher & Co. director Teresa Hillary Clarke reported an acquisition of 1,110 shares of common stock as a grant or award, at a stated price of $0.00 per share. This award is structured as restricted stock units that vest on the earlier of one year after the grant date or her departure from the Board.
Following this compensation-related award, Clarke directly holds a total of 5,566.726 shares of Arthur J. Gallagher & Co. common stock. The transaction reflects routine equity compensation for board service rather than an open-market purchase or sale.